- Home
- XLO vs OSTX Comparison
XLO vs OSTX Comparison
Compare XLO & OSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XLO
- OSTX
- Stock Information
- Founded
- XLO 2016
- OSTX 2018
- Country
- XLO United States
- OSTX United States
- Employees
- XLO N/A
- OSTX N/A
- Industry
- XLO Biotechnology: Pharmaceutical Preparations
- OSTX
- Sector
- XLO Health Care
- OSTX
- Exchange
- XLO Nasdaq
- OSTX NYSE
- Market Cap
- XLO 37.9M
- OSTX 36.2M
- IPO Year
- XLO 2021
- OSTX 2024
- Fundamental
- Price
- XLO $0.80
- OSTX $1.60
- Analyst Decision
- XLO Buy
- OSTX Strong Buy
- Analyst Count
- XLO 1
- OSTX 2
- Target Price
- XLO $4.00
- OSTX $17.50
- AVG Volume (30 Days)
- XLO 2.7M
- OSTX 2.2M
- Earning Date
- XLO 03-11-2025
- OSTX 03-25-2025
- Dividend Yield
- XLO N/A
- OSTX N/A
- EPS Growth
- XLO N/A
- OSTX N/A
- EPS
- XLO N/A
- OSTX N/A
- Revenue
- XLO $6,344,000.00
- OSTX N/A
- Revenue This Year
- XLO $707.71
- OSTX N/A
- Revenue Next Year
- XLO $26.48
- OSTX $26,663.99
- P/E Ratio
- XLO N/A
- OSTX N/A
- Revenue Growth
- XLO N/A
- OSTX N/A
- 52 Week Low
- XLO $0.58
- OSTX $1.41
- 52 Week High
- XLO $1.93
- OSTX $7.00
- Technical
- Relative Strength Index (RSI)
- XLO 43.56
- OSTX N/A
- Support Level
- XLO $0.73
- OSTX N/A
- Resistance Level
- XLO $0.98
- OSTX N/A
- Average True Range (ATR)
- XLO 0.10
- OSTX 0.00
- MACD
- XLO -0.02
- OSTX 0.00
- Stochastic Oscillator
- XLO 23.26
- OSTX 0.00
About XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the significant need for new treatments in cancers of the bone in children and young adults.